Mycobacteria, Culture, with Fluorochrome Smear
*Build Your Own Panel Eligible [?]
|
$190
|
|
|
Description:
There are more than 70 species of mycobacteria of which the primary pathogen is M. tuberculosis. Tuberculosis is a chronic, granulomatous disease caused by M. tuberculosis. Identification, and, if appropriate, antibiotic sensitivity, is required to initiate necessary therapy.
Categories:
Price:
$190
|
|
Mycobacteria Stain, Acid-Fast, Fluorochrome
*Build Your Own Panel Eligible [?]
|
$160
|
|
|
Description:
Used to evaluate a patient's tuberculosis communicability status.
Categories:
Price:
$160
|
|
Mycobacterium avium-intracellulare DNA, Qualitative, Real-Time PCR
*Build Your Own Panel Eligible [?]
|
$818
|
|
|
Description:
This test is used to detect the presence of either M. avium or M. intracellulare in a patient's specimen. The use of Real-Time PCR to assay for the presence of M. avium and/or M. intracellulare DNA in clinical specimens allows for rapid patient testing (3 to 4 hours compared to several weeks or more for conventional culture and DNA hybridization) and for distinguishing infections caused by M. tuberculosis or other mycobacterial species.
Categories:
Price:
$818
|
|
Mycobacterium, Culture, Blood
*Build Your Own Panel Eligible [?]
|
$281
|
|
|
Description:
Since the mid-1980s and expanding size of the immunocompromised patient population, the incidence of septicemia caused by opportunistic pathogens such as yeast, fungi and mycobacteria has risen. Mycobacterium tuberculosis (MTB) complex and mycobacteria other than tuberculosis (MOTT), especially Mycobacterium avium complex (MAC), have become resurgent.The Centers for Disease Control and Prevention (CDC) have recommended that every effort must be made for laboratories to use the most rapid methods available for diagnostic mycobacteria testing. These recommendations include the use of a liquid medium for mycobacterial culture. The BD BACTEC fluorescent series instruments are designed for the rapid detection of microorganisms in clinical specimens.
Categories:
Price:
$281
|
|
Mycobacterium, Identification
*Build Your Own Panel Eligible [?]
|
$273
|
|
|
Description:
The identification of mycobacteria is important for the control, management and treatment of diseases caused by this group of organisms.
Categories:
Price:
$273
|
|
Mycobacterium tuberculosis Complex and Rifampin Resistance, PCR, Non-Sputum
*Build Your Own Panel Eligible [?]
|
$868
|
|
|
Description:
Globally, about 2 billion people are infected with MTB. In 2010, 8.8 million people developed active disease and 1.4 million people lost their lives to the illness. There were 9951 new cases of tuberculosis reported in the United States in 2012 (a rate of 3.2 cases per 100,000). In 2011, 536 deaths were attributed to tuberculosis infections.Standard treatment regimens for tuberculosis involve prolonged administration of multiple drugs and is usually highly effective. However, MTB-complex strains that are resistant to one or more of first line drugs require individualized treatment. Rifampin resistance is often an indication of multidrug resistance to tuberculosis (MDR TB), which is defined as resistance to at least rifampin (RIF) and isoniazid (INH). In the Unites States overall RIF resistance is approximately 1.8% with approximately 90% of these strains resistant to at least RIF and INH.
Categories:
Price:
$868
|
|
Mycobacterium tuberculosis Complex and Rifampin Resistance, PCR, Sputum
*Build Your Own Panel Eligible [?]
|
$868
|
|
|
Description:
Globally, about 2 billion people are infected with MTB. In 2010, 8.8 million people developed active disease and 1.4 million people lost their lives to the illness. There were 9951 new cases of tuberculosis reported in the United States in 2012 (a rate of 3.2 cases per 100,000). In 2011, 536 deaths were attributed to tuberculosis infections.Standard treatment regimens for tuberculosis involve prolonged administration of multiple drugs and is usually highly effective. However, MTB-complex strains that are resistant to one or more of first line drugs require individualized treatment. Rifampin resistance is often an indication of multidrug resistance to tuberculosis (MDR TB), which is defined as resistance to at least rifampin (RIF) and isoniazid (INH). In the Unites States overall RIF resistance is approximately 1.8% with approximately 90% of these strains resistant to at least RIF and INH.Active pulmonary TB is a highly infectious airborne disease. All patients in healthcare facilities with suspected TB should be maintained in respiratory isolation according to recommended infection control guidelines. Patients with HIV infection and pulmonary TB are more likely to have sputum samples that are acid-fast bacilli (AFB) smear negative than patients with pulmonary TB alone. Overall rates of detection of MTB-complex with the Xpert (TM) MTB/RIF Assay may be lower in settings with a high percentage of HIV-infected patients relative to populations where the percentage of patients with HIV infection is lower and AFB smear-positive TB is higher.
Categories:
Price:
$868
|
|
Mycobacterium tuberculosis Complex, PCR, Culture and Smear, Non-Respiratory
*Build Your Own Panel Eligible [?]
|
$557
|
|
|
Description:
There are more than 70 species of Mycobacteria of which the primary pathogen is M. tuberculosis. Tuberculosis is a chronic, granulomatous disease caused by M. tuberculosis. Identification, and, if appropriate, antibiotic sensitivity, is required to initiate necessary therapy.
Categories:
Price:
$557
|
|
Mycobacterium tuberculosis Complex, PCR, Culture and Smear, Respiratory
*Build Your Own Panel Eligible [?]
|
$557
|
|
|
Description:
There are more than 70 species of Mycobacteria of which the primary pathogen is M. tuberculosis. Tuberculosis is a chronic, granulomatous disease caused by M. tuberculosis. Identification, and, if appropriate, antibiotic sensitivity, is required to initiate necessary therapy.
Categories:
Price:
$557
|
|
Mycobacterium tuberculosis Complex, PCR, Non-Respiratory
*Build Your Own Panel Eligible [?]
|
$490
|
|
|
Description:
Used to aid the physician in the rapid diagnosis and treatment of a possible tuberculosis infection.
Categories:
Price:
$490
|
|
Mycobacterium tuberculosis Complex, PCR, Respiratory
*Build Your Own Panel Eligible [?]
|
$490
|
|
|
Description:
Used to aid the physician in the rapid diagnosis and treatment of a possible tuberculosis infection.
Categories:
Price:
$490
|
|
Mycobacterium tuberculosis Complex, Rifampin Resistance, Culture/PCR,Sputum
*Build Your Own Panel Eligible [?]
|
$935
|
|
|
Description:
Tuberculosis caused by Mycobacterium (M.) tuberculosis (TB) complex organisms remains a major global and public health problem with tuberculosis being cited as the leading cause of death due to a single infectious agent.
Categories:
Price:
$935
|
|
Mycophenolic Acid, LC/MS/MS
*Build Your Own Panel Eligible [?]
|
$440
|
|
|
Description:
Mycophenolic acid is an immunosuppressant used in tissue transplants. It prevents graft rejection by the host's immune system. It is very important to monitor its level. Too little of this drug will cause graft rejection, while too much will lead to infection. Monitoring its level is essential to optimize therapeutic effects, avoid toxicity, and assure compliance.
Categories:
Price:
$440
|
|
Mycoplasma genitalium rRNA, NAAT with Reflex to Macrolide Resistance
*Build Your Own Panel Eligible [?]
|
$397
|
|
|
Description:
This test is for the detection of Mycoplasma genitalium and macrolide resistance markers in M. genitalium positive samples. Macrolide resistance testing may be useful for resistance-guided therapy in patients with M. genitalium infection. A two-stage therapy approach which includes doxycycline as the initial empiric therapy and follow-up treatment based on results from resistance testing is recommended.M.genitalium is a sexually transmitted bacteria that can cause urethritis in men and cervicitis and pelvic inflammatory disease in women. Resistance to macrolides has been increasing and contributes to treatment failure, although rates of resistance vary by geographical region and patient population. Doxycycline is recommended as the initial empiric therapy, followed by azithromycin for patients with macrolide sensitive M. genitalium infections or moxifloxacin for macrolide resistant infections. This approach is aimed at reducing organism load and facilitates clearance, ultimately decreasing the risk of treatment failure in infected patients.A detected macrolide resistance result for this test indicates that the organism contains one of the characterized mutations (A2056G, A2058C, A2059G, A2059C, A2058T) associated with the resistance to macrolides. Although a not detected result may suggest a macrolide sensitive infection, macrolide resistance may still be present even when markers are not detected due to differences in analytical sensitivity between the detection of M.genitalium nucleic acid and markers of resistance. Analytical sensitivity may also vary based on the specific mutation associated with the macrolide resistance.References:1. Wood, GE, et al. Update in epidemiology and management of Mycoplasma genitalium infections. Infec. Dis. Clin., 37 (2) (2023), pp. 311-3332. Workowski, K, et al. CDC Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23; 70(4):1-187.3. Machalek, DA, et al. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta- analysis. Lancet Infect Dis. 2020 Nov;20(11):1302-1314.
Categories:
Price:
$397
|
|
Mycoplasma genitalium, rRNA, TMA
*Build Your Own Panel Eligible [?]
|
$397
|
|
|
Description:
The Aptima Mycoplasma genitalium assay is an in vitro nucleic acid amplification test (NAAT) for the qualitative detection of ribosomal RNA (rRNA) from Mycoplasma genitalium. It is intended for use as an aid in the diagnosis of M. genitalium urogenital infections in male and female patients suspected of M. genitalium infection. Infection with M. genitalium was shown to be strongly associated with non-gonococcal urethritis (NGU) in men and cervicitis in women. Infection with M. genitalium is associated with increased risk for cervicitis, pelvic inflammatory disease, preterm birth, spontaneous abortion, and infertility. M. genitalium infections largely go unrecognized, as infected individuals are either asymptomatic or have symptoms similar to those associated with other bacterial infections of the urogenital tract.
Categories:
Price:
$397
|
|
Mycoplasma pneumoniae Antibodies (IgG, IgM)
*Build Your Own Panel Eligible [?]
|
$297
|
|
Description:
- Detects past Mycoplasma pneumoniae infection.
- Checks current and past lung infections.
- Measures body response to lung bacteria.
Includes:
Mycoplasma pneumoniae Antibodies (IgG, IgM)
Categories:
Price:
$297
|
|
Mycoplasma pneumoniae Antibody (IgG)
*Build Your Own Panel Eligible [?]
|
$184
|
|
|
Description:
Mycoplasma are the smallest of the free-living organisms. M. pneumoniae causes approximately 10-20% of all cases of pneumonia. These pneumonias that can affect otherwise healthy individuals, are commonly referred to as "walking" and "atypical" pneumonias.
Categories:
Price:
$184
|
|
Mycoplasma pneumoniae Antibody (IgM)
*Build Your Own Panel Eligible [?]
|
$260
|
|
|
Description:
Mycoplasma is the smallest of the free-living organisms. M. pneumoniae causes approximately 10-20% of all cases of pneumonia. These pneumonias that can affect otherwise healthy individuals, are commonly referred to as "walking" and "atypical" pneumonias.
Categories:
Price:
$260
|
|
Mycoplasma pneumoniae DNA, Qualitative, Real-Time PCR
*Build Your Own Panel Eligible [?]
|
$724
|
|
|
Description:
Mycoplasma pneumoniae DNA, PCR, is a highly sensitive method to detect the presence of Mycoplasma pneumoniae DNA in clinical specimens. The diagnosis of Mycoplasma pneumoniae infection should not rely solely upon the result of a PCR assay. A positive result should be determined in conjunction with clinical presentation and additional established clinical tests. Moreover, this assay cannot differentiate between viable and nonviable organisms. A negative PCR result indicates the absence of Mycoplasma pneumoniae DNA at detectable levels in the sample tested and does not exclude the diagnosis of disease.
Categories:
Price:
$724
|
|
Mycoplasma pneumoniae IgA
*Build Your Own Panel Eligible [?]
|
$303
|
|
|
Description:
Mycoplasma pneumoniae is a widely distributed bacterium and causes primary atypical pneumonia, often called "walking pneumonia". M. pneumonia can be cultured on artificial media but may take 21-30 days for growth to appear. Alternatively, M. pneumoniae IgA antibodies may be used for rapid and specific identification of this disease.A negative serological result does not exclude infection, as in early phase of infection, antibodies may not be present, or may be too low to be detectable. A borderline result indicates a solid (negative or positive) result was not obtained. A positive result indicates contact with the bacterium, Mycoplasma pneumoniae.
Categories:
Price:
$303
|
|
Mycoplasma/Ureaplasma Panel
*Build Your Own Panel Eligible [?]
|
$937
|
|
|
Description:
Mycoplasma and Ureaplasma spp. have been associated with genital tract infection. M. genitalium has been implicated in cervicitis, endometritis, and PID. M. hominis has also been associated with cervicitis and is present in increased numbers in vaginosis. Ureaplasma spp. have been linked to upper genitourinary tract infection and to premature labor and abortion. Because of their nature, these organisms are not routinely cultured and are better detected by molecular methods. Recently, by molecular means two groups of Ureaplasma spp. have been distinguished- U. parvum and U. urealyticum, with the former being more prevalent in the lower genital tract of a healthy woman. It is not clear which species more predominantly causes infection. M. hominis and the ureaplasmas appear to be opportunists when they infect the upper genitourinary tract. These organisms have also been targeted as having a possible role in infertility, although this remains a gray area.
Categories:
Price:
$937
|
|
MYD88, Mutation Analysis
*Build Your Own Panel Eligible [?]
|
$984
|
|
|
Description:
Oncogenic mutations in MYD88, in particular the L265P mutation, have been identified as driver mutations in various B-cell lymphomas. The L265P mutation is found in approximately 90% of Waldenstom macroglobulinemia and IgM-expressing lymphoplasmacytic lymphoma (LPL). There is a low incidence of L265P MYD88 mutation in other systemic CD5-negative B-cell lymphoproliferative disorders including atypical chronic lymphocytic leukemia, nodal marginal zone lymphoma (MZL), splenic MZL and mucosa-associated lymphoid tissue (MALT)-type MZL. This next-generation sequencing (NGS) based assay detects clinically significant MYD88 mutations, including the L265P mutation and can be used to help diagnose Waldenstrom macroglobulinemia or IgM-expressing lymphoplasmacytic lymphoma and to help in stratifying or subclassifying patients with IgM monoclonal gammopathy.
Categories:
Price:
$984
|
|
Myelin Antibody (IgG), IFA
*Build Your Own Panel Eligible [?]
|
$349
|
|
|
Description:
Antibodies against myelin are found in multiple sclerosis and other neurological diseases. However, the diagnostic value of this serum antibody is controversial, as high titers in healthy subjects can also be detected. Antibodies against myelin-associated glycoproteins are present at times with Guillain-Barre syndrome.
Categories:
Price:
$349
|
|
Myelin-Associated Glycoprotein (MAG) Antibody (IgM), EIA
*Build Your Own Panel Eligible [?]
|
$352
|
|
Description:
- Check for nerve-related antibody activity
- Screen for unexplained numbness and tingling
- Track nerve symptoms over time
Categories:
Price:
$352
|
|
Myelin Associated Glycoprotein (MAG)-SGPG Antibody (IgM)
*Build Your Own Panel Eligible [?]
|
$340
|
|
|
Description:
MAG, Antibody IgM is useful in detecting antibodies associated with autoimmune peripheral neuropathy.
Categories:
Price:
$340
|
|
Myelin Basic Protein
*Build Your Own Panel Eligible [?]
|
$359
|
|
|
Description:
The concentration of MBP is often increased in patients with demyelinating diseases such as multiple sclerosis and may be increased in patients with head injury, CNS trauma, tumor, stroke, and viral encephalitis.
Categories:
Price:
$359
|
|
Myelin Oligodendrocyte Glycoprotein(MOG)Antibody with Reflex to Titer,CSF
*Build Your Own Panel Eligible [?]
|
$1187
|
|
|
Description:
Neuromyelitis optica (NMO) is an inflammatory disorder predominantly affecting the optic nerves and spinal cord. Limited forms of disease including isolated optic neuritis, brainstem encephalitis and longitudinal extensive transverse myelitis (LETM) or acute disseminated encephalomyelitis (ADEM) have been referred to as NMO spectrum disorder (NMOSD). The majority of individuals with NMO and many with NMOSD have antibodies against aquaporin 4 (AQP4). MOG antibodies have been reported without AQP4 antibodies in individuals with NMO and other non-multiple sclerosis demyelinating diseases. The presence of MOG antibodies in AQP4 antibody negative individuals can help differentiate between multiple sclerosis (MS) and non-MS demyelinating diseases and aid in clinical management decisions.
Categories:
Price:
$1187
|
|
Myelin Oligodendrocyte Glycoprotein(MOG)Antibody with Reflex to Titer,Serum
*Build Your Own Panel Eligible [?]
|
$1187
|
|
|
Description:
Neuromyelitis optica (NMO) is an inflammatory disorder predominantly affecting the optic nerves and spinal cord. Limited forms of disease including isolated optic neuritis, brainstem encephalitis and longitudinal extensive transverse myelitis (LETM) or acute disseminated encephalomyelitis (ADEM) have been referred to as NMO spectrum disorder (NMOSD). The majority of individuals with NMO and many with NMOSD have antibodies against aquaporin 4 (AQP4). MOG antibodies have been reported without AQP4 antibodies in individuals with NMO and other non-multiple sclerosis demyelinating diseases. The presence of MOG antibodies in AQP4 antibody negative individuals can help differentiate between multiple sclerosis (MS) and non-MS demyelinating diseases and aid in clinical management decisions.
Categories:
Price:
$1187
|
|
Myeloma Detection Panel, Basic
*Build Your Own Panel Eligible [?]
|
$560
|
|
|
Description:
International Myeloma Working Group (IMWG) recommends multiple component testing as Standard of Care for identification of patient with Multiple Myeloma.
Categories:
Price:
$560
|
|
Myeloma Detection Panel, Comprehensive
*Build Your Own Panel Eligible [?]
|
$856
|
|
|
Description:
International Myeloma Working Group (IMWG) recommends multiple component testing as Standard of Care for identification of patient with Multiple Myeloma.
Categories:
Price:
$856
|
|
Myeloperoxidase(13)
*Build Your Own Panel Eligible [?]
|
$246
|
|
|
Description:
Autoimmune vasculitis diseases are characterized by abnormal immune responses that result in inflammation and necrosis of blood vessels. The immune dysfunction may be triggered by infection, autoimmune disease, or exposure to a drug; often the cause is unknown. ANCA-associated vasculitis diseases are often characterized by the size of the blood vessels involved. The diseases present with diverse clinical features and are often rapidly progressive, causing irreversible injury to the vessels of the organs affected, such as the kidneys and lungs.
Alternative names: Anti-Myeloperoxidase,Churg-Strauss Syndrome,Crescentic Glomeruloephritis,MPO
Patient Instructions:
Fasting is not required.
Categories:
Gastrointestinal diseases,
Price:
$246
|
|
Myeloperoxidase (MPO), IHC with Interpretation
*Build Your Own Panel Eligible [?]
|
$442
|
|
|
Description:
This marker can be used to aid in the diagnosis and/or prognosis of cancer. The clinical interpretation of any staining or its absence should be complemented by morphological studies using proper controls and should be evaluated within the context of the patient's clinical history and other diagnostic tests by a qualified pathologist.
Categories:
Price:
$442
|
|
Myeloproliferative Neoplasms (MPN) Core Diagnostic Panel
*Build Your Own Panel Eligible [?]
|
$2550
|
|
|
Description:
The MPN Core Diagnostic panel is an evidence-based, disease targeted mutational analysis panel, performed by Next-generation sequencing (NGS). Testing for disease-defining driver mutations in JAK2 V617F, JAK2 exon 12, CALR, and MPL, as part of the early evaluation for BCR-ABL1-negative myeloproliferative neoplasms (MPNs) including polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), assists with diagnosis; is supported by medical guidelines; should be performed using highly sensitive molecular methods; and also impacts prognosis and therapy selection. The panel tests nucleic acid harvested from leukocytes from blood or bone marrow specimens.This panel does NOT include testing for the BCR-ABL1 rearrangement, which can be detected using BCR-ABL1 Gene Rearrangement, Quantitative, PCR or FISH, CML/ALL, BCR/ABL Translocation 9;22. MPN patients who are found to be pan-negative (~10% of cases) on the MPN Core Diagnostic panel may be candidates for CSF3R Mutation Analysis or Quest?s LeukoVantage®, Myeloproliferative Neoplasms (MPN), which offers an expanded panel of gene targets supported by medical literature. Results of this assay should be correlated with morphology and other clinical and laboratory findings for definitive diagnosis and classification.
Categories:
Price:
$2550
|
|
Myeloproliferative Neoplasms (MPN) Mini Panel
*Build Your Own Panel Eligible [?]
|
$2550
|
|
|
Description:
The MPN mini profile detects disease-defining, potentially targetable mutations in JAK2, CALR, and MPL for myeloproliferative neoplasms. These 3 genes are growth- promoting oncogenes that operate through a signaling pathway mediated by JAK2, and MPNs with these mutations can respond to clinically available JAK2 inhibitors. The inclusion of hot spot mutation testing in these 3 genes into the routine workup of MPNs is recommended by the World Health Organization's classifications of hematological malignancies and the National Comprehensive Cancer Network (NCCN) guidelines. This combined testing method provides diagnostic assistance, provides a clonal molecular marker of disease following diagnosis and post therapy follow-up, influences prognosis, and identifies those MPNs that may potentially benefit from JAK2 inhibitor therapy.
Categories:
Price:
$2550
|
|
Myocardial Antibody Screen with Reflex to Titer
*Build Your Own Panel Eligible [?]
|
$392
|
|
|
Description:
Myocardial Antibody Screen is useful in detecting myocardial disease that includes an immunologic component. These diseases include various cardiomyopathies, especially idiopathic dilated cardiomyopathy, myocarditis, rheumatic fever, and Dressler's syndrome.
Categories:
Price:
$392
|
|
Myoglobin, Serum
*Build Your Own Panel Eligible [?]
|
$355
|
|
|
Description:
Assessment of skeletal muscle breakdown (rhabdomyolysis)
Categories:
Price:
$355
|
|
Myositis Specific 11 Antibody Panel
*Build Your Own Panel Eligible [?]
|
$2101
|
|
|
Description:
Myositis-specific autoantibodies (MSAs) are highly selective, usually exclusive and are associated with particular clinical phenotypes within the myositis spectrum. Myositis-specific autoantibodies to cytoplasmic enzymes that catalyze the binding of specific amino acids to their cognate tRNA define the anti-synthetase syndrome characterized by myositis and lung inflammation, and include autoantibodies to Jo-1 (antihistidyl-tRNA synthetase), PL-7 (threonyl), PL-12 (alanyl), EJ (glycyl), and OJ (isoleucyl). A further subset of myositis patients is characterized by the presence of autoantibodies directed against the signal recognition particle (SRP). Autoantibodies to Mi-2 (Mi-2/nucleosome remodeling and deacetylase (NuRD) complex) are detected in patients with hallmark dermatomyositis features. Autoantibody to a cytoplasmic 140-kDa protein, melanoma-differentiation associated gene 5 (MDA5), also known as anti-CADM140, identified patients with clinically amyopathic dermatomyositis (CADM) and rapidly progressive lung disease. Autoantibodies to transcriptional intermediary factor 1-gamma (TIF-1 y), a p155/140 nuclear protein involved in cellular differentiation, have been reported in adult and juvenile dermatomyositis; in adults, it is associated with malignancy. Autoantibodies to nuclear matrix protein NXP-2, another 140-kDa protein, is found in juvenile dermatomyositis (JDM). Anti-TIF-1 y and anti-NXP-2, two novel serological subsets in JDM, occur collectively in >40% of children and appear to identify those with more severe disease.
Categories:
Price:
$2101
|
|
NAbFeron® (IFNΒ-1) Neutralizing Antibody Test
*Build Your Own Panel Eligible [?]
|
$1845
|
|
|
Description:
Detection of neutralizing antibodies to InterferonB-1.
Categories:
Price:
$1845
|
|
Natural Bodybuilder Panel
|
$341
|
|
|
Description:
This test uses equilibrium dialysis methodology.
The Testosterone test in this panel will provide levels of Total Testosterone results ranging from 0 to 9,999. However, any value greater than 9,999 will be displayed as ">10,000" (over 10,000) instead of a specific number.
Includes:
Complete Blood Count / CBC (includes Differential and Platelets): WBC, RBC, Hemoglobin, Hematocrit, MCV, MCH, MCHC, RDW, Platelet Count, MPV and Differential (Absolute and Percent - Neutrophils, Lymphocytes, Monocytes, Eosinophils, and Basophils) Comprehensive Metabolic Profile ( includes eGFR ): Albumin, Albumin/Globulin Ratio (calculated), Alkaline Phosphatase, ALT, AST, BUN/Creatinine Ratio (calculated), Calcium, Carbon Dioxide, Chloride, Creatinine with GFR Estimated, Globulin (calculated), Glucose, Potassium, Sodium, Total Bilirubin, Total Protein, Urea Nitrogen Insulin-Like Growth Factor I (IGF-I). Estradiol, Ultrasensitive, LC/MS/MS Total Testosterone, Free (Dialysis) Testosterone (calculated) Lipid Panel: Cholesterol, total; high-density lipoprotein (HDL) cholesterol; low-density lipoprotein (LDL) cholesterol (calculated); triglycerides; Non-HDL Cholesterol (calculated). T3 Uptake; T4 (Thyroxine), Total; Free T4 Index (T7); Thyroid-Stimulating Hormone (TSH) Follicle-stimulating Hormone (FSH) and Luteinizing Hormone (LH) Sex Hormone binding Globulin, Serum.
Patient Instructions:
You should fast for 12-14 hours before collection of the specimen. Fasting is defined as no consumption of food or beverage other than water for at least 12-14 hours before testing. Some tests in this panel may exhibit interference when sample is collected from a person who is consuming a supplement with a high dose of biotin (also termed as vitamin B7 or B8, vitamin H or coenzyme R). If using a testosterone cream please be sure you have not rubbed any into the antecubital area of your arm for the last 24 hours as it can give elevated results. Patient should be cautioned to stop biotin consumption at least 72 hours prior to the collection of a sample. Estimated turnaround for results is 10 business days. If confirmation testing is required, the estimated time may be extended.
Categories:
Price:
$341
|
|
Natural Killer Cells
*Build Your Own Panel Eligible [?]
|
$325
|
|
Description:
- Checks immune cells fighting infections or cancer
- Measures body's natural defense cell levels
- Looks at key cells in your immunity
Includes:
Natural Killer Cells
Categories:
Price:
$325
|
|
Neisseria gonorrhoeae (GC) Culture
*Build Your Own Panel Eligible [?]
|
$216
|
|
|
Description:
Neisseria gonorrhoeae is considered a pathogen whenever isolated and its identification is important in initiating appropriate therapy to prevent the spread of the infection as well as the serious sequelae.
Categories:
Price:
$216
|
|
Neisseria gonorrhoeae RNA, TMA, Rectal
*Build Your Own Panel Eligible [?]
|
$49
|
|
|
Description:
Neisseria gonorrhoeae may infect the anal/rectal canal of sexually active individuals. Detection of this organism may be important for determining the risk for disease progression or transmission.
Categories:
Price:
$49
|
|
Neisseria gonorrhoeae RNA, TMA, Throat
*Build Your Own Panel Eligible [?]
|
$49
|
|
|
Description:
Neisseria gonorrhoeae may infect the oral/pharyngeal cavity of sexually active individuals. Detection of this organism may be important for determining the risk for disease progression or transmission.
Categories:
Price:
$49
|
|
Neisseria gonorrhoeae, TMA (Alternate Target), Rectal
*Build Your Own Panel Eligible [?]
|
$347
|
|
|
Description:
Neisseria gonorrhoeae may infect the anal/rectal canal of sexually active individuals. Detection of this organism may be important for determining the risk for disease progression or transmission.
Categories:
Price:
$347
|
|
Neisseria gonorrhoeae, TMA (Alternate Target), Urogenital
*Build Your Own Panel Eligible [?]
|
$49
|
|
|
Description:
Several methods are available for the detection of N. gonorrhoeae in clinical specimens. These methods include: Observation of gram-negative intracellular diplococci in gram-stained smears of urethral discharges from men and of endocervical secretions from women; Growth of N. gonorrhoeae from the urethra (men) or endocervix on selective culture media followed by demonstration of typical colonial morphology; and/or detection of N. gonorrhoeae with non-culture laboratory tests. A definitive diagnosis of gonorrhoea requires: Isolation of N. gonorrhoeae from the sites of exposure by culture; demonstration of typical colonial morphology, a positive oxidase test, and typical gram-negative morphology; And finally, a confirmation by specific identification methods. These confirmation methods may include acid production from carbohydrates, rapid enzyme tests, serologic assays, and tests for specific nucleic acids, such as is performed by the CT/NG APTIMA® TMA Assay.
Categories:
Price:
$49
|
|
Neisseria meningitidis, IgG, Vaccine Response, MAID
*Build Your Own Panel Eligible [?]
|
$477
|
|
|
Description:
This assay measures serum IgG antibodies recognizing polysaccharide antigens from the four Neisseria meningitidis serogroups included in the licensed meningococcal vaccine. The meningococcal vaccine response is best evaluated by testing pre-vaccination and post-vaccination samples in parallel. A two-fold or greater increase for at least two serogroups is expected when comparing post-vaccination to pre-vaccination results. N. Meningitidis IgG levels peak approximately one month post-vaccination, but decline markedly by two years.
Categories:
Price:
$477
|
|
Nemaline Myopathy
*Build Your Own Panel Eligible [?]
|
$788
|
|
|
Description:
The nemaline myopathy test offers molecular detection of one pathogenic variant in the NEB gene, 2502 bp DEL (c.7431+1917 7536+372del2502), which accounts for greater than 95% of Ashkenazi-Jewish nemaline myopathy pathogenic variants.Nemaline myopathy is an autosomal recessive myopathy characterized by the presence of nemaline rods in muscle tissue. Clinical features include muscle weakness, typically most severe in the neck, face, and limbs, which may result in difficulties in breathing, feeding, and speech, as well as delayed motor functions.
Categories:
Price:
$788
|
|
NeoCerebellar Degeneration Paraneoplastic Profile with Recombx®
*Build Your Own Panel Eligible [?]
|
$4976
|
|
|
Description:
Anti-CV2, anti-Hu, anti-Ma, anti-Ta, anti-Ri, anti-Yo, anti-Zic4 antibodies, and anti-GAD65 are found in patients with acute or subacute symptoms of cerebellar degeneration including gait ataxia, nystagmus and/or dysarthria, and opsoclonus/myoclonus. This semi-quantitative assay may be useful in monitoring therapeutic responses in select cases.
Categories:
Price:
$4976
|
|
NeoComplete Paraneoplastic Evaluation with Recombx®
*Build Your Own Panel Eligible [?]
|
$10285
|
|
|
Description:
Anti-Hu, anti-CV2, anti-Yo, anti-Ri, anti-CAR, anti-Ma, anti-Ta, anti-Zic4 antibodies, anti-voltage gated calcium channels (VGCC), anti-P/Q type and voltage gated potassium channels (VGKC), anti- Ganglionic AChR, anti-Amphiphysin, anti-NMDA receptor (NR1-subunit), anti-LGI1, anti-CASPR2, and anti-GAD65 are found in patients with the acute or subacute onset of limbic encephalitis, brainstem encephalitis, focal cortical encephalitis, myelitis, cerebellar degeneration, opsoclonus/myoclonus, retinopathy, sensory neuropathy, autonomic dysfunction, Stiff Person Syndrome and/or Lambert-Eaton Myasthenic Syndrome. This semi-quantitative assay may be useful in monitoring therapeutic responses in select cases.
Categories:
Price:
$10285
|
|
NeoEncephalitis Paraneoplastic Evaluation with Recombx®
*Build Your Own Panel Eligible [?]
|
$6201
|
|
|
Description:
Anti-Hu, anti-CV2, anti-Ma, anti-Ta, anti-voltage gated potassium channels (VGKC), anti-Amphiphysin, anti-GAD65, anti-NMDA receptor (NR1-subunit), anti- LGI1, and anti-CASPR2 antibodies are found in patients with the acute or subacute onset of limbic encephalitis including confusion/dementia, depression/anxiety and/or seizures or hallucinations and usually MRI changes in medial temporal lobes. This semi-quantitative assay may be useful in monitoring therapeutic responses in select cases.
Categories:
Price:
$6201
|
